LHDX News and Press, Lucira Health Inc. From 08/01/21

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

EMERYVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced t...

While being riskier bets, small or mid-cap companies have greater potential for higher returns than their large cap counterparts. But it is necessary to acknowledge that the probability of achieving these high returns is pretty low. For now, there are two undervalued g...

Although the pandemic has mostly faded from the front pages, mutations of the SARS-CoV-2 virus are increasing the odds that COVID will make a resurgence this winter. Add in many Americans' hesitancy over vaccines, and it appears the companies providing testing, treatments, and vaccine boost...

Gainers: Tempest Therapeutics (TPST) +98%, Xtant Medical (XTNT) +31%, Celldex Therapeutics CLDX +29%, SCWorx (WORX) +20%, ReShape Lifesciences (RSLS) +12%.Losers: Sigilon Therapeutics (SGTX) -9%, TransMedics (TMDX) -8%, Prothena PRTA...

Shares of Lucira Health (NASDAQ: LHDX) -- a maker of consumer-friendly at-home COVID-19 tests -- climbed as much as 40% higher Friday afternoon. The move prompted a temporary halt in trading of shares. There was no news from the company. Shares remain up more than 20% as of ...

JuSun/iStock via Getty Images Lucira Health ([[LHDX]] +32.1%) has added more than a third of its value today as the shares of the med-tech firm focused on infectious disease test kits are set to reach their highest level since mid-April. As shown in the graph, the company has lost more t...

Gainers: Alector (ALEC) +69%. Lucira Health (LHDX) +9%. Provention Bio (PRVB) +7%.Losers: Iterum Therapeutics (ITRM) -34%. Arrowhead Pharmaceuticals (ARWR) -26%. Alterity Therapeutics (ATHE) -21%. Citius Pharmaceuticals (CTXR) -20%. TRxADE HEALTH (MEDS) -17%. For fu...